Axxcess Wealth Management LLC trimmed its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 6.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 9,482 shares of the medical equipment provider’s stock after selling 611 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Intuitive Surgical were worth $4,949,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical during the third quarter worth $558,807,000. Proficio Capital Partners LLC lifted its stake in Intuitive Surgical by 89,098.8% in the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after purchasing an additional 948,902 shares in the last quarter. FMR LLC boosted its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB increased its holdings in shares of Intuitive Surgical by 15,322.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
ISRG has been the subject of several research analyst reports. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Robert W. Baird reduced their price target on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday. Leerink Partners increased their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $611.86.
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $483.95 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market capitalization of $172.37 billion, a price-to-earnings ratio of 75.50, a PEG ratio of 5.85 and a beta of 1.43. The stock has a 50 day moving average price of $565.43 and a 200 day moving average price of $531.90.
Insiders Place Their Bets
In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Golden Cross Stocks: Pattern, Examples and Charts
- 3 Must-Own Stocks to Build Wealth This Decade
- Upcoming IPO Stock Lockup Period, Explained
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.